B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
about
Novel applications of Rituximab in dermatological disordersVascular involvement in systemic sclerosis (scleroderma).Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.Libby amphibole-induced mesothelial cell autoantibodies promote collagen deposition in mice.B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence.Skin sclerosis as a manifestation of POEMS syndrome.
P2860
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@en
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@nl
type
label
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@en
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@nl
prefLabel
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@en
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@nl
P2860
P1476
B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
@en
P2093
Minoru Hasegawa
P2860
P356
10.1111/J.1346-8138.2009.00763.X
P577
2010-01-01T00:00:00Z